MD, FRCPC, FCAP
Preferred method of communication
Research and teaching
- Applications of Cell-Free DNA and Next-Generation Sequencing to Hematopoietic Malignancies
Summary of Research
Dr. Mahe is currently the principle investigator on a prospective study of Cell-Free DNA in B-cell Non-Hogkin’s Lymphoma. He is a co-investigator on several studies of clinical applications of Metabolomic profiling in lymphomas and myeloid neoplasia. Dr. Mahe is also co-investigator with and affiliate of the CLS Hematology lab, which is currently validating a number of NGS assays for use in the work-up fo hematologic malignancies. His ongoing work also includes the development and validation of novel immune cell profiling assays, for which he holds a patent. Dr. Mahe is also well-versed in the design of informatic pipelines for NGS data analysis.
Dr. Mahe is a pathologist in the division of Hematology of Calgary Lab Services. He has fellowship training in the application of NGS-based technologies to cancer testing. Dr. Mahe also has a strong interest in the genetics of B and T-cell clonality, as well as cutaneous lymphoproliferative disorders